USA - NASDAQ:APVO - US03835L5049 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to APVO. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating | 
|---|---|---|---|
| 2024-09-23 | Roth MKM | Maintains | Buy -> Buy | 
| 2022-05-13 | Piper Sandler | Maintains | Overweight | 
| 2021-05-28 | Roth Capital | Maintains | Buy | 
7 analysts have analysed APVO and the average price target is 428.4 USD. This implies a price increase of 30280.82% is expected in the next year compared to the current price of 1.4101.
The consensus rating for APTEVO THERAPEUTICS INC (APVO) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.